Market News AIOpen the app

GKOS stock news · Glaukos Corporation

Stories about Glaukos Corporation (GKOS) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for GKOS

Follow Glaukos Corporation (GKOS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for GKOS
Free on the App Store and Google Play, or on the web.
  1. Nov 4, 2026, 7:41 AM ET · Market

    An insider at Glaukos sold $10,618,980 worth of shares, according to a recent SEC filing.

    Neutral

    A Glaukos insider sold about $10.6 million in shares, but the filing gives no reason. It reports no change to the business, so the sale alone does not show a shift in Glaukos's outlook.

  2. Oct 9, 2026, 12:56 PM ET · Market

    Glaukos shows that its new eye treatment lowers eye pressure better when used with cataract surgery.

    Good for GKOS

    Glaukos reported its implant plus cataract surgery lowered eye pressure more than surgery alone, with no reported treatment-related corneal or macular problems over 3 months. The results support its outlook.